secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evofem Biosciences, Inc. (EVFM)
CIK:        0001618835
Form:       8-K
Filed at:   2025-05-08T23:59:59+00:00
Accession:  0001641172-25-009248
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evofem Biosciences amends supply agreement with UAE partner to add 3-Pack product size
--------------------------------------------------------------------------------

- Amendment adds 3-applicator package size (3-Pack) to existing Development and Supply Agreement with Pharma 1 Drug Store L.L.C.
- Pricing for 3-Pack is firm through Dec 31, 2025; specific price redacted as confidential.
- Mixed-size batches (3-Pack and 12-Pack) allowed at Licensor-approved ratios; additional packaging costs paid by Licensee.
- Order lead time remains at least six months; batch size is 96,000 applicators.
- All other terms of the original July 17, 2024 agreement remain unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1618835/000164117225009248/0001641172-25-009248-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1618835/000164117225009248/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-009248

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer